Clinical Considerations For The Treatment Of The Elderly Cll Patient

Clinical Considerations for the Treatment of the Elderly CLL Patient

Clinical Considerations for the Treatment of Elderly MCL Patients

Managing Elderly Patients With CLL

Targeted Oncology

The management of elderly patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

How to treat eldery CLL patients

VJHemOnc – Video Journal of Hematology & HemOnc

How to treat elderly CLL patients in the light of novel therapies

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Barrientos on the Management of Elderly Patients with CLL

Age Impacts Treatment Options for Patients With CLL

Targeted Oncology

CLL-Frail trial: efficacy & safety of acalabrutinib in elderly (≥80y) and/or frail patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Venetoclax for the Treatment of Elderly Patients With CLL

Targeted Oncology

Underrepresentation of elderly patients with CLL in clinical trials

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical considerations when treating patients with CLL with BTK inhibitors

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Ferrajoli on Treatment of Elderly Patients With CLL

Dr. Ferrajoli on the Management of CLL in Elderly Patients

Targeted Oncology

BCEEEF 2011: Different options for elderly CLL patients

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Case 1: An Elderly Patient With Newly Diagnosed High-Risk CLL

Targeted Oncology

Dr. Ferrajoli on Managing CLL in Elderly Patients

Breakthroughs in the treatment of elderly patients with AML

VJHemOnc – Video Journal of Hematology & HemOnc

Comprehensive geriatric assessments can aid in selecting treatment for elderly patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc